Actualités Imagine Lithium Inc - ILI | Actions TSX Venture Exchange

Interleukin Genetics to Present at the 12th Annual BIO CEO Conference

WALTHAM, Mass., Feb. 4 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that it will make a corporate...

LABEC Pharma to Begin Selling Interleukin Genetics' Heart Health Genetic Test in Europe

WALTHAM, Mass. and MADRID, Jan. 19 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) and LABEC Pharma, S.L. announced today...

Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone Mi

Test Available Under Inherent Health(TM) Brand Promotes Early Action for Fracture Prevention with Recommendations for Improving Bone Health...

Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York

WALTHAM, Mass., Dec. 7 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it has received approval by the...

Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis

New Study Published in Annals of Rheumatic Diseases Suggests IL-1 Biology Plays Central Role in Development of Severe Knee Osteoarthritis WALTHAM...

Interleukin Genetics Reports Third Quarter 2009 Financial Results

WALTHAM, Mass., Nov. 12 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) today announced financial and operational results...

Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 Results

WALTHAM, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that it will host a conference call...

Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic Tests

WALTHAM, Mass. and ADA, Mich., Oct. 29 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it has entered into...

Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings

WALTHAM, Mass., Oct. 13 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it will present new genetic...

Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss

Subjects on Diets Appropriate for their Genotype Achieved Statistically significant Average Weight Loss of 6.2% of Body Weight at one year...

Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness

Brand Includes New Weight Management Genetic Test that Provides Evidence-Based Guidance on Best Diet and Exercise Choices for Individuals...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Imagine Lithium Inc (ILI)

Outils de qualité professionnelle, pour des investisseurs individuels.

ILI Actualités

Interleukin Genetics to Present at the 12th Annual BIO CEO Conference

LABEC Pharma to Begin Selling Interleukin Genetics' Heart Health Genetic Test in Europe

Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone Mi

Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York

Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis

Interleukin Genetics Reports Third Quarter 2009 Financial Results

Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 Results

Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic Tests

Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings

Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss

Interleukin Genetics Reports Second Quarter 2009 Financial Results

Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results

Interleukin Genetics Announces Strategic Divestment of Alan James Group

Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Imagine Lithium Inc (ILI) Actualités

Imagine Lithium Inc (ILI)

Outils de qualité professionnelle, pour des investisseurs individuels.

ILI Actualités

Interleukin Genetics to Present at the 12th Annual BIO CEO Conference

LABEC Pharma to Begin Selling Interleukin Genetics' Heart Health Genetic Test in Europe

Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone Mi

Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York

Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis

Interleukin Genetics Reports Third Quarter 2009 Financial Results

Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 Results

Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic Tests

Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings

Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss

Interleukin Genetics Reports Second Quarter 2009 Financial Results

Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results

Interleukin Genetics Announces Strategic Divestment of Alan James Group

Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités